January 19, 2026

Look Again! Demodex Blepharitis in Closer Focus

Why Demodex blepharitis deserves more attention – and how a quick diagnostic check can improve patient care

The Ophthalmologist

January 13, 2026

Intense Pulsed Light for Dry Eye

Three-session IPL strategy demonstrates stronger, longer-lasting gains for dry eye patients

The Ophthalmologist

January 12, 2026

Medable Debuts AI Agent for Automating Trial Master File Processes

New capability frees up human capital from one of the biggest labor costs in clinical research

The Medicine Maker

January 09, 2026

Can a Benign Hematology Phenomenon Critically Impact the Neutropenia Status and Treatment of Patients With Cancer?

Understanding benign ethnic neutropenia (BEN) and its implications can prevent unnecessary treatment interruptions for cancer patients of African descent.

JADPRO

January 09, 2026

Home-Based Monitoring Could Transform Care for Patients Receiving T-Cell Redirecting Therapies

A study found that outpatient observation cut hospital stays dramatically, with no adverse safety events reported. It also freed up inpatient beds and cut healthcare costs.

Fox Chase Cancer Center

January 09, 2026

Flipped Nivolumab/Ipilimumab Dosing Improves Responses, Survival, and Safety in Advanced Melanoma

The flipped dose for nivolumab 3 mg/kg and ipilimumab 1 mg/kg led to improved response rates and survival findings as well as lower severe immune-related toxicities compared with the standard dose of ...

The ASCO Post

January 09, 2026

AAN Issues Guideline on Functional Seizures

Psychological interventions nearly double the odds of seizure freedom; benzodiazepines and antiseizure medications not recommended without co-occurring epilepsy

Conexiant

January 09, 2026

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura

The FDA's approval of recombinant ADAMTS13 marks a significant advancement in managing congenital thrombotic thrombocytopenic purpura, ensuring better care for patients suffering from this rare condition.

JADPRO

January 09, 2026

A Rare Case of Acute Hemolysis After Rasburicase Infusion

A case study highlights the critical need for awareness of G6PD deficiency in CLL patients on venetoclax, following a rare hemolytic reaction to rasburicase.

JADPRO